The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer

Lung cancer causes over one million deaths every year worldwide. However, prevention and treatment methods for this serious disease are limited. The identification of new chemicals related to lung cancer may aid in disease prevention and the design of more effective treatments. This study employed a weighted network, constructed using chemical-chemical interaction information, to identify new chemicals related to two types of lung cancer: non-small lung cancer and small-cell lung cancer. Then, a randomization test as well as chemical-chemical interaction and chemical structure information were utilized to make further selections. A final analysis of these new chemicals in the context of the current literature indicates that several chemicals are strongly linked to lung cancer.

[1]  R. Mason,et al.  Requirement of arsenic biomethylation for oxidative DNA damage. , 2009, Journal of the National Cancer Institute.

[2]  S. Wise,et al.  Hexavalent Chromium-Induced DNA Damage and Repair Mechanisms , 2008, Reviews on environmental health.

[3]  T. Hirano,et al.  Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. , 1991, Journal of immunology.

[4]  C. Eng,et al.  Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 , 2011, Human molecular genetics.

[5]  S. Nesnow,et al.  DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. , 2002, Chemical research in toxicology.

[6]  E. Hölttä.  Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase. , 1977, Biochemistry.

[7]  H. Sasaki,et al.  PIK3CA mutation status in Japanese lung cancer patients. , 2006, Lung cancer.

[8]  V. Pongrakhananon,et al.  Ouabain enhances lung cancer cell detachment. , 2014, Anticancer research.

[9]  Jing Lu,et al.  A hybrid method for prediction and repositioning of drug Anatomical Therapeutic Chemical classes. , 2014, Molecular bioSystems.

[10]  N. Sunaga,et al.  Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report , 2014, Journal of Medical Case Reports.

[11]  M. Relling,et al.  Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancer , 2008, Cancer.

[12]  Dara L Aisner,et al.  Molecular pathology of non-small cell lung cancer: a practical guide. , 2012, American journal of clinical pathology.

[13]  Adam B. Olshen,et al.  Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis , 2009, Bioinform..

[14]  Y. Shima,et al.  Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. , 1994, Blood.

[15]  Christian von Mering,et al.  STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..

[16]  S. Tsao,et al.  Molecular changes during arsenic‐induced cell transformation , 2011, Journal of cellular physiology.

[17]  David Harrington,et al.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.

[18]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[19]  P. Woster,et al.  Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity , 2005, Cancer Chemotherapy and Pharmacology.

[20]  A. MacKinnon,et al.  Extracellular matrix regulation of drug resistance in small-cell lung cancer , 2007, International journal of radiation biology.

[21]  M. Lindstrom,et al.  A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model. , 2009, Cancer research.

[22]  A. Vincent,et al.  P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer , 2002, Neurology.

[23]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[24]  Huiqing Liu,et al.  Discovery of significant rules for classifying cancer diagnosis data , 2003, ECCB.

[25]  Damian Szklarczyk,et al.  STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..

[26]  Yu-Dong Cai,et al.  Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein Interactions , 2014, PloS one.

[27]  Hui Gao,et al.  Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1α under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells , 2013, International journal of molecular sciences.

[28]  T. Grigliatti,et al.  A Correlation between Cytotoxicity and Reductase-Mediated Metabolism in Cell Lines Treated with Doxorubicin and Daunorubicin , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[29]  K. O'Byrne,et al.  EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. , 2012, The Lancet. Oncology.

[30]  A. Paiardini,et al.  SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation , 2014, Cell Death and Disease.

[31]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[32]  R. Read.  [Systemic effects of smoking]. , 1984, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[33]  Xuejun Jiang,et al.  Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. , 2012, The international journal of biochemistry & cell biology.

[34]  F. Beck,et al.  Nutritional and zinc status of head and neck cancer patients: an interpretive review. , 1998, Journal of the American College of Nutrition.

[35]  I. Umelo,et al.  Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu. , 2012, Lung cancer.

[36]  M. Mishima,et al.  All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[37]  Radhey S. Gupta,et al.  Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis) , 1986, Journal of cellular physiology.

[38]  Hélène Laurent,et al.  Lung cancer: what are the links with oxidative stress, physical activity and nutrition. , 2013, Lung cancer.

[39]  J. Rüschoff,et al.  HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  B. Diwan,et al.  Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[42]  Jie Liu,et al.  Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. , 2008, Free radical biology & medicine.

[43]  K. Chou,et al.  Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities , 2012, PloS one.

[44]  S. Toyooka,et al.  Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. , 2010, The Lancet. Oncology.

[45]  David A. Cosgrove,et al.  Lead Hopping Using SVM and 3D Pharmacophore Fingerprints , 2005, J. Chem. Inf. Model..

[46]  P. Bork,et al.  Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.

[47]  A. Sugawara,et al.  All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. , 2007, Endocrinology.

[48]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[49]  J. Downward,et al.  Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase , 1998, The EMBO journal.

[50]  J. Bavaria,et al.  Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer. , 1996, Cancer investigation.

[51]  A. Pegg,et al.  Polyamine catabolism and disease. , 2009, The Biochemical journal.

[52]  H. Sugimura,et al.  PIK3CA mutation and amplification in human lung cancer , 2007, Pathology international.

[53]  R. Wilson,et al.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[55]  B. Diwan,et al.  Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype , 2009, Environmental health perspectives.

[56]  H. Qi,et al.  Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis , 2014, Journal of Translational Medicine.

[57]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[58]  C. Yu,et al.  Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells. , 1998, Life sciences.

[59]  J. Minna,et al.  Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. , 2005, Cancer research.

[60]  M. Webber,et al.  Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. , 2002, Journal of the National Cancer Institute.

[61]  S. Katiyar,et al.  p53 cooperates berberine‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo , 2009, Molecular carcinogenesis.

[62]  D. Ghosh,et al.  FUNCTIONAL SIGNIFICANCE OF A NATURAL ALLELIC VARIANT OF HUMAN CARBONYL REDUCTASE 3 (CBR3) , 2005, Drug Metabolism and Disposition.

[63]  Taro Matsumoto,et al.  Digoxin inhibits neuroblastoma tumor growth in mice. , 2005, Anticancer research.

[64]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  M. Kheir,et al.  Acute toxicity of berberine and its correlation with the blood concentration in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[67]  C. Lim,et al.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? , 2010, Progress in cardiovascular diseases.

[68]  Stefan Günther,et al.  SuperPred: drug classification and target prediction , 2008, Nucleic Acids Res..

[69]  Polycarpos Pissis,et al.  Role of oxidative stress and DNA damage in human carcinogenesis. , 2011, Mutation research.

[70]  T. Ciuleanu,et al.  Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  I. Saiki,et al.  Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer , 2013, Oncology letters.

[72]  R. Singal,et al.  Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy. , 2015, Clinical genitourinary cancer.

[73]  A. Prasad.  Effects of zinc deficiency on Th1 and Th2 cytokine shifts. , 2000, The Journal of infectious diseases.

[74]  P. Bross,et al.  Emerging roles for riboflavin in functional rescue of mitochondrial β-oxidation flavoenzymes. , 2010, Current medicinal chemistry.

[75]  Chun‐Chieh Wu,et al.  Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma. , 2013, Life sciences.

[76]  Kuo-Chen Chou,et al.  Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions , 2011, PloS one.

[77]  M. Shibuya,et al.  Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4 , 2006, Oncogene.

[78]  Y. Shima,et al.  Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. , 1994, Blood.

[79]  D. Kershenobich,et al.  Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus‐related liver cirrhosis , 2006, Cancer.

[80]  J. Y. Liu,et al.  Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells , 2006, Archives of Toxicology.

[81]  M. Wigler,et al.  Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. , 2003, Cancer cell.

[82]  S. Hirano,et al.  Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat Liver , 2004, Toxicologic pathology.

[83]  Lakshmanan K. Iyer,et al.  A combined approach to data mining of textual and structured data to identify cancer-related targets , 2006, BMC Bioinformatics.

[84]  A. J. Gandolfi,et al.  Monomethylarsonous acid induces transformation of human bladder cells. , 2006, Toxicology and applied pharmacology.

[85]  Lei Chen,et al.  Prediction of Metabolic Pathway Using Graph Property, Chemical Functional Group and Chemical Structural Set , 2013 .

[86]  Antonio Marchetti,et al.  Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features , 2006, International journal of cancer.

[87]  P. Chanvorachote,et al.  Ouabain mediates integrin switch in human lung cancer cells. , 2014, Anticancer research.

[88]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[89]  Liying Wang,et al.  Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. , 2012, Toxicology and applied pharmacology.

[90]  S. Toma,et al.  Retinoids in lung cancer chemoprevention and treatment. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[91]  Jie Liu,et al.  Transplacental arsenic carcinogenesis in mice. , 2007, Toxicology and applied pharmacology.

[92]  L. Böhm,et al.  Influence of ouabain on cell inactivation by irradiation. , 1996, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[93]  C. Teng,et al.  Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. , 2004, Biochemical pharmacology.

[94]  Saul Espinosa Gómez,et al.  Induction of DNA damage by free radicals generated either by organic or inorganic arsenic (AsIII, MMAIII, and DMAIII) in cultures of B and T lymphocytes , 2007, Biological Trace Element Research.

[95]  A. J. Gandolfi,et al.  A Population-based Case–Control Study of Urinary Arsenic Species and Squamous Cell Carcinoma in New Hampshire, USA , 2013, Environmental health perspectives.

[96]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  W. Cullen,et al.  Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells , 2000, Archives of Toxicology.

[98]  A. J. Gandolfi,et al.  Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[99]  Lei Chen,et al.  Identification of Lung-Cancer-Related Genes with the Shortest Path Approach in a Protein-Protein Interaction Network , 2013, BioMed research international.

[100]  Ananda S. Prasad,et al.  Zinc in Cancer Prevention , 2009, Nutrition and cancer.

[101]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[102]  H. Chang,et al.  Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. , 1999, The American journal of Chinese medicine.

[103]  J. von Pawel,et al.  Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[105]  E. Tokar,et al.  Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[106]  Masahiro Fukuoka,et al.  Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  Jun Chen,et al.  Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes , 2004, BMC Bioinformatics.

[108]  B. Diwan,et al.  Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice , 2012, Archives of Toxicology.

[109]  V. Pongrakhananon,et al.  Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis. , 2013, American journal of physiology. Cell physiology.

[110]  Juan Zhou,et al.  Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. , 2008, Life sciences.

[111]  Andrew D. Yates,et al.  Athletics: Momentous sprint at the 2156 Olympics? , 2004, Nature.

[112]  T. Shi,et al.  Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif , 2008, Acta Pharmacologica Sinica.

[113]  E. Ben-Chetrit,et al.  Colchicine: 1998 update. , 1998, Seminars in arthritis and rheumatism.

[114]  J. Ward,et al.  Cancer in experimental animals exposed to arsenic and arsenic compounds , 2010, Critical reviews in toxicology.

[115]  J. Riordan.  Biochemistry of zinc. , 1976, The Medical clinics of North America.

[116]  Ralph Weissleder,et al.  Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.

[117]  M. Štěrba,et al.  Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron , 2009, Pharmacological reports : PR.

[118]  T. Suga,et al.  Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. , 2002, American journal of respiratory cell and molecular biology.

[119]  T. Nakano,et al.  All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice , 2009, European Respiratory Journal.

[120]  S. Goldfinger.  Colchicine for familial Mediterranean fever. , 1972, The New England journal of medicine.

[121]  WachiShinichiro,et al.  Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues , 2005 .

[122]  H. Yoshizawa,et al.  Simultaneous determination of berberine, palmatine and coptisine in crude drugs and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. , 1982, Chemical & pharmaceutical bulletin.